StockData

Zhengye Biotechnology Holding Ltd (ZYBT) stock

ZYBTNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.50−0.02 (-1.32%)

Close on Nov 18, 2026Market cap $71.09MP/E –Yield –

Zhengye Biotechnology pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Zhengye Biotechnology's pe ratio was 21.9× on Feb 27, 2026, against 44.4× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Feb 27, 202621.9×−10.2
2025Dec 31, 202532.2×–

More Zhengye Biotechnology figures

See a number that looks wrong?